Viewing StudyNCT00118053



Ignite Creation Date: 2024-05-05 @ 11:44 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00118053
Status: TERMINATED
Last Update Posted: 2013-11-20
First Post: 2005-07-08

Brief Title: Trastuzumab Docetaxel and Carboplatin in Treating Women With Stage II Stage III or Inflammatory Breast Cancer
Sponsor: University of Medicine and Dentistry of New Jersey
Organization: Rutgers The State University of New Jersey

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
stage IIIC breast cancer View
inflammatory breast cancer View
stage II breast cancer View
stage IIIA breast cancer View
stage IIIB breast cancer View